Novocure Ltd expected to post a loss of 41 cents a share - Earnings Preview

NovoCure

23/07/2024 16:21

* Novocure Ltd  NVCR.OQ   NVCR.O  is expected to show a rise
in
quarterly revenue when it reports  results on July 25 for the
period ending June 30 2024
    * The Saint Helier Jersey-based   company is expected to
report a
7.8% increase in revenue to $135.823 million from $126.05
million a year ago, according to the mean estimate from 7
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Novocure Ltd is for a
loss
of 41 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Novocure
Ltd is
$26.00​, above​ its last closing price of $18.88. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.42       -0.42      -0.36     Beat    14.8
 Jan. 1 2024   -0.51       -0.52      -0.45     Beat    13.7
 Sep. 30 2023  -0.53       -0.52      -0.46     Beat    12.4​
 Jun. 30 2023  -0.49       -0.50      -0.54     Missed  -7.9
 ​​Mar.        -0.31       -0.32      -0.50     Missed  -54.5
 31 2023                                                
 Jan. 1 0001   -0.31       -0.30      -0.36     Missed  -18​
 Sep. 30 2022  -0.26       -0.26      -0.25     Beat    4.4
 Jun. 30 2022  -0.16       -0.14      -0.23     Missed  -58.6
 This summary was machine generated July 23 at 15:21 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)